Cite
KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.
MLA
Mi Na Kim, et al. “KASL Clinical Practice Guidelines for Noninvasive Tests to Assess Liver Fibrosis in Chronic Liver Disease.” Clinical & Molecular Hepatology, vol. 30, no. 3, Sept. 2024, pp. S5–105. EBSCOhost, https://doi.org/10.3350/cmh.2024.0506.
APA
Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, & Dae Won Jun. (2024). KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease. Clinical & Molecular Hepatology, 30(3), S5–S105. https://doi.org/10.3350/cmh.2024.0506
Chicago
Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, et al. 2024. “KASL Clinical Practice Guidelines for Noninvasive Tests to Assess Liver Fibrosis in Chronic Liver Disease.” Clinical & Molecular Hepatology 30 (3): S5–105. doi:10.3350/cmh.2024.0506.